SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-013936
Filing Date
2023-08-08
Accepted
2023-08-08 16:12:29
Documents
63
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q olma-20230630x10q.htm   iXBRL 10-Q 1912880
2 EX-31.1 olma-20230630xex31d1.htm EX-31.1 13569
3 EX-31.2 olma-20230630xex31d2.htm EX-31.2 13619
4 EX-32.1 olma-20230630xex32d1.htm EX-32.1 10465
  Complete submission text file 0001558370-23-013936.txt   6518145

Data Files

Seq Description Document Type Size
5 EX-101.SCH olma-20230630.xsd EX-101.SCH 36892
6 EX-101.CAL olma-20230630_cal.xml EX-101.CAL 48277
7 EX-101.DEF olma-20230630_def.xml EX-101.DEF 120107
8 EX-101.LAB olma-20230630_lab.xml EX-101.LAB 372899
9 EX-101.PRE olma-20230630_pre.xml EX-101.PRE 269325
57 EXTRACTED XBRL INSTANCE DOCUMENT olma-20230630x10q_htm.xml XML 1021486
Mailing Address 780 BRANNAN STREET SAN FRANCISCO CA 94103
Business Address 780 BRANNAN STREET SAN FRANCISCO CA 94103 (415) 651-3316
Olema Pharmaceuticals, Inc. (Filer) CIK: 0001750284 (see all company filings)

IRS No.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39712 | Film No.: 231151441
SIC: 2834 Pharmaceutical Preparations